IT201800007017A1 - Aptameri per l'uso nella terapia, prevenzione, diagnosi e rilevamento del papillomavirus - Google Patents

Aptameri per l'uso nella terapia, prevenzione, diagnosi e rilevamento del papillomavirus Download PDF

Info

Publication number
IT201800007017A1
IT201800007017A1 IT102018000007017A IT201800007017A IT201800007017A1 IT 201800007017 A1 IT201800007017 A1 IT 201800007017A1 IT 102018000007017 A IT102018000007017 A IT 102018000007017A IT 201800007017 A IT201800007017 A IT 201800007017A IT 201800007017 A1 IT201800007017 A1 IT 201800007017A1
Authority
IT
Italy
Prior art keywords
seq
aptamers
papillomavirus
dna
epitopes
Prior art date
Application number
IT102018000007017A
Other languages
English (en)
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IT102018000007017A priority Critical patent/IT201800007017A1/it
Priority to PCT/IT2019/050159 priority patent/WO2020008489A2/fr
Priority to EP19750180.2A priority patent/EP3818160A2/fr
Publication of IT201800007017A1 publication Critical patent/IT201800007017A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT102018000007017A 2018-07-06 2018-07-06 Aptameri per l'uso nella terapia, prevenzione, diagnosi e rilevamento del papillomavirus IT201800007017A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT102018000007017A IT201800007017A1 (it) 2018-07-06 2018-07-06 Aptameri per l'uso nella terapia, prevenzione, diagnosi e rilevamento del papillomavirus
PCT/IT2019/050159 WO2020008489A2 (fr) 2018-07-06 2019-07-05 Aptamères destinés à être utilisés dans la thérapie, la prévention, le diagnostic et la détection du papillomavirus
EP19750180.2A EP3818160A2 (fr) 2018-07-06 2019-07-05 Aptamères destinés à être utilisés dans la thérapie, la prévention, le diagnostic et la détection du papillomavirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102018000007017A IT201800007017A1 (it) 2018-07-06 2018-07-06 Aptameri per l'uso nella terapia, prevenzione, diagnosi e rilevamento del papillomavirus

Publications (1)

Publication Number Publication Date
IT201800007017A1 true IT201800007017A1 (it) 2020-01-06

Family

ID=63834386

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102018000007017A IT201800007017A1 (it) 2018-07-06 2018-07-06 Aptameri per l'uso nella terapia, prevenzione, diagnosi e rilevamento del papillomavirus

Country Status (3)

Country Link
EP (1) EP3818160A2 (fr)
IT (1) IT201800007017A1 (fr)
WO (1) WO2020008489A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113481205B (zh) * 2021-07-30 2023-11-03 杭州凡泰生物科技有限公司 一种hpv18类病毒颗粒的核酸适配体hpv1801及其应用
CN117737311B (zh) * 2024-02-20 2024-04-19 湖南派智生物科技有限公司 检测犬乳头瘤病毒的通用引物对、试剂、试剂盒及应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DIANA GABRIELA VALENCIA-RESÉNDIZ ET AL: "Inhibition of Human Papillomavirus Type 16 Infection Using an RNA Aptamer", NUCLEIC ACID THERAPEUTICS, vol. 28, no. 2, 1 April 2018 (2018-04-01), US, pages 97 - 105, XP055573246, ISSN: 2159-3337, DOI: 10.1089/nat.2017.0687 *
JEREMIAH J. TRAUSCH ET AL: "Development and Characterization of an HPV Type-16 Specific Modified DNA Aptamer for the Improvement of Potency Assays", ANALYTICAL CHEMISTRY, vol. 89, no. 6, 21 March 2017 (2017-03-21), US, pages 3554 - 3561, XP055573298, ISSN: 0003-2700, DOI: 10.1021/acs.analchem.6b04852 *

Also Published As

Publication number Publication date
EP3818160A2 (fr) 2021-05-12
WO2020008489A3 (fr) 2020-02-13
WO2020008489A2 (fr) 2020-01-09

Similar Documents

Publication Publication Date Title
CN112480217B (zh) 基于SARS-CoV-2的S抗原蛋白的疫苗和组合物
RU2707251C2 (ru) Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
DK2850189T3 (en) COMPOSITIONS AND PROCEDURES FOR MODULATING GENEPRESSION
JP4643906B2 (ja) 遺伝子発現の標的化阻害のための合成二本鎖オリゴヌクレオチド
ES2749855T3 (es) Procedimientos y composiciones para la inhibición específica de glicolato oxidasa (hao1) por ARN bicatenario
JP2020515258A (ja) 抗ウイルス治療剤
EA008940B1 (ru) Антивирусные олигонуклеотиды, не связанные с комплементарностью последовательностей
KR20190063482A (ko) 마이크로rna 화합물 및 mir-21 활성 조절 방법
York et al. Genetic analysis of heptad-repeat regions in the G2 fusion subunit of the Junin arenavirus envelope glycoprotein
TW201249991A (en) Modulation of TIMP1 and TIMP2 expression
CN102498211A (zh) 特异结合胰腺癌细胞或组织的核酸适体及其用途
US20260022379A1 (en) Optimized RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Genomes, Compositions Thereof, and Methods of Use
US20130345284A1 (en) siRNA Compositions and Methods for Treatment of HPV and Other Infections
EP3369820B1 (fr) Aptamère d'adn capable de se lier au facteur de von willebrand (vwf)
Zhang et al. Targeting folded RNA: a branched peptideboronic acid that binds to a large surface area of HIV-1 RRE RNA
EP3818160A2 (fr) Aptamères destinés à être utilisés dans la thérapie, la prévention, le diagnostic et la détection du papillomavirus
CA2226457C (fr) Oligonucleotides specifiques contre le papillomavirus humain
JP6986263B2 (ja) 抗ウイルス薬
TW202246510A (zh) 以crispr/slucas9治療第1型肌強直性營養不良之組合物及方法
WO2026021236A1 (fr) Polypeptide capable d'inhiber une infection à coronavirus de type mers et son utilisation
CN117642179A (zh) 流感病毒核酸脂质颗粒疫苗
JP7764502B2 (ja) 環状ＲＮＡ Ｃｉｒｃ－ＡＣＥ２翻訳によるポリペプチド及びその使用
WO2020154594A2 (fr) Compositions et procédés de traitement du virus du papillome humain
EP2943593A1 (fr) Diagnostic et traitement de maladies virales
US20250297264A1 (en) Rna aptamer targeting of adam8 in cancer growth and metastasis